...
首页> 外文期刊>Cancer biology & therapy >Mismatch repair gene expression and genetic instability in testicular germ cell tumor.
【24h】

Mismatch repair gene expression and genetic instability in testicular germ cell tumor.

机译:睾丸生殖细胞肿瘤中的错配修复基因表达和遗传不稳定。

获取原文
获取原文并翻译 | 示例
           

摘要

Human mismatch repair (MMR) genes encode highly conserved interacting proteins that correct replication errors predisposing to hereditary gastrointestinal and genitourinary malignancies. A subset of sporadic genitourinary tumors also exhibits MMR deficiency and can be identified by measuring the frequency of microsatellite instability (MSI) in cancer cell DNA. We investigated expression of the two most commonly mutated MMR genes, MSH2 and MLH1, in sporadic testicular germ cell tumor (GCT) in order to: (1) determine the expression pattern of MSH2 and MLH1 proteins in normal seminiferous tubules and histologically distinct GCT subtypes, (2) correlate MMR gene expression with genetic instability in GCT and (3) develop a panel of molecular markers that can identify genetically distinct subsets of GCT for prognostic assessment. MSH2 and MLH1 had differential staining patterns in normal seminiferous tubules and malignant tissues. MSH2 was expressed in all stages of spermatogenesis up to but excluding mature sperm whereas MLH1 was predominantly expressed in premeiotic germ cells. All histological GCT subtypes showed differential immunostaining for MSH2 and MLH1 however pure seminoma had statistically significant fewer low MSH2 staining tumors than other subtypes (p = 0.046). Twenty-five percent of GCT exhibited increased frequency of MSI (MSI+ tumors) with 73, 70 and 43% of MSI+ tumors exhibiting low MSH2, low MLH1 or low MSH2 and low MLH1 staining respectively. Fifteen percent of testicular GCT exhibited loss of heterozygosity (LOH) but no MSI (LOH only tumors). Only 28, 17 or 6% of LOH only tumors exhibited low MSH2, low MLH1 or low MSH2 and low MLH1 staining respectively.
机译:人错配修复(MMR)基因编码高度保守的相互作用蛋白,可纠正因遗传性胃肠道和泌尿生殖系统恶性肿瘤而导致的复制错误。散发性泌尿生殖系统肿瘤的一部分也表现出MMR缺乏,可以通过测量癌细胞DNA中微卫星不稳定性(MSI)的频率来鉴定。我们研究了偶发性睾丸生殖细胞肿瘤(GCT)中两个最常见的MMR基因突变MSH2和MLH1的表达,以:(1)确定正常生精小管和组织学不同的GCT亚型中MSH2和MLH1蛋白的表达模式,(2)将MMR基因表达与GCT中的遗传不稳定性相关联;(3)开发一组分子标记,可以鉴定GCT的遗传学上不同的子集以进行预后评估。 MSH2和MLH1在正常的曲细精管和恶性组织中具有不同的染色模式。 MSH2在直至但不包括成熟精子的精子发生的所有阶段均表达,而MLH1主要在减数分裂前的生殖细胞中表达。所有组织学GCT亚型均显示出MSH2和MLH1的差异免疫染色,但与其他亚型相比,纯精原细胞瘤的低MSH2染色肿瘤在统计学上显着减少(p = 0.046)。 25%的GCT显示MSI(MSI +肿瘤)的频率增加,其中73%,70%和43%的MSI +肿瘤分别显示低MSH2,低MLH1或低MSH2和低MLH1染色。 15%的睾丸GCT表现出杂合性缺失(LOH),但无MSI(仅LOH肿瘤)。仅28、17或6%的仅LOH肿瘤分别显示出低MSH2,低MLH1或低MSH2和低MLH1染色。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号